This content was published on
Housing prices in Switzerland rose significantly again in the third quarter of 2026. Both single-family homes and flats saw sharp price increases compared with the previous quarter.
Osteoporosis in Switzerland going undiagnosed and untreated
This content was published on
According to the International Osteoporosis Foundation (IOF), around 684,000 women affected by the condition in Switzerland do not receive any treatment.
Swiss pharma giant Roche presents positive data on eye disease drug
This content was published on
Basel-based pharmaceutical company Roche has reported positive Phase III results for its eye disease treatment, vamikibart.
Swiss food firms bet on protein ingredients as demand for meat alternatives slows
This content was published on
Swiss start-ups focused on plant-based nutrition are shifting their attention to the B2B market, selling protein ingredients rather than finished products.
This content was published on
“Consumer spending in Switzerland continues to grow, although at a slightly slower pace than over the summer,” analysts at PostFinance said.
This content was published on
New regulations will leave lender with options ranging from retaining billions of dollars of additional capital to shrinking international operations.
Explainer: Watches win, pharma waits as Swiss-India trade deal turns one
This content was published on
In October 2025, Switzerland, as a member state of EFTA, entered into what was billed as a historic free trade deal with India.
